Overexpression of ADAM species is known in tumor cell lines, for example, ADAM10, ADAM12 and ADAM15 in hematological malignant tumor cell lines [30], and ADAM9, ADAM10, ADAM15 and ADAM17 in prostate cancer cell lines [31]. This evidence concerns the gene ADAM17 and prostate carcinoma.